Skip to main content
. 2016 Dec 12;17(4):1470320316668435. doi: 10.1177/1470320316668435

Figure 8.

Figure 8.

Effects of comorbidities on serum ACE2 activity in cardiovascular patients.

The effects of comorbidities such as dyslipidemia (panel (a)), atrial fibrillation (AF, panel (b)), diabetes (panel (c)) and gender (panel (d)) are shown in cardiovascular patients (healthy, hypertensive without heart failure, heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF)). Statistical differences between patient groups with and without of the defined comorbidity are indicated: asterisks represent statistically significant differences, NS represents no significant statistical difference. Statistical analysis was made by a nonparametric test (Kruskal–Wallis).